Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) has issued an announcement.
TheraCryf PLC, a company involved in the pharmaceutical industry, has announced a significant change in its voting rights structure. T and I Limited has acquired a 7.5131% stake in TheraCryf, as reported on March 14, 2025, following the crossing of the threshold on March 11, 2025. This acquisition may impact the company’s governance and influence future strategic decisions.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For an in-depth examination of TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue